| Literature DB >> 27089360 |
Montserrat Fitó1, Valentini Konstantinidou2.
Abstract
The synergies and cumulative effects among different foods and nutrients are what produce the benefits of a healthy dietary pattern. Diets and dietary patterns are a major environmental factor that we are exposed to several times a day. People can learn how to control this behavior in order to promote healthy living and aging, and to prevent diet-related diseases. To date, the traditional Mediterranean diet has been the only well-studied pattern. Stroke incidence, a number of classical risk factors including lipid profile and glycaemia, emergent risk factors such as the length of telomeres, and emotional eating behavior can be affected by genetic predisposition. Adherence to the Mediterranean diet could exert beneficial effects on these risk factors. Our individual genetic make-up should be taken into account to better prevent these traits and their subsequent consequences in cardiovascular disease development. In the present work, we review the results of nutritional genomics explaining the role of the Mediterranean diet in human cardiovascular disease. A multidisciplinary approach is necessary to extract knowledge from large-scale data.Entities:
Keywords: dietary pattern; nutrigenetics; prevention
Mesh:
Year: 2016 PMID: 27089360 PMCID: PMC4848687 DOI: 10.3390/nu8040218
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Proposed nutritional genomics mechanisms. The “Nutri-” prefix in the name of each of the 4 categories defines the influence of nutrition on genomics/epigenomics, proteomics, metabolomics and genetics/epigenomics.
Nutrigenetics, nutrigenomics, nutri-metabolomics, and nutri-miRomics studies related to Mediterranean diet interventions in humans.
| Nutrigenetics | SNPs Tested | Outcome | Reference |
|---|---|---|---|
| rs7903146 (homozygotes for the T risk allele) at the TCF7L2 gene. | Increased fasting glucose, total cholesterol, LDL-C, TG, stroke incidence | [ | |
| rs3812316 (carriers of the G protective allele) at the MLXIPL gene. | Lower TG, reduction in CVD risk | [ | |
| rs1801282 (carriers of the Ala-G protective allele) at the PPARγ2 gene. | Higher adherence to the Mediterranean diet strengthens the prevention of telomere shortening | [ | |
| rs1801260 in the CLOCK gene (homozygous for the major T allele). | Triggering glucose metabolism in patients with metabolic syndrome | [ | |
| rs1801260 in the CLOCK gene (carriers of the minor C allele) | Less weight loss for the C carriers with high emotional score (emotional eaters). | [ | |
| Protective modulation ( | Pro-atherosclerotic in vascular inflammation, foam cell formation, thrombosis, oxidative stress | [ | |
| Protective modulation ( | Artery wall production of inflammatory mediators | [ | |
| Canonical pathways modulation. | Atherosclerosis, hypertension, renin-angiotensin, nitric oxide, angiopoietin signaling, hypoxia, eNOS signaling pathways | [ | |
| Plasma from individuals with MetS. | altered metabolic profile | [ | |
| Urine from non-diabetic adults. | Classification of individuals by evaluating changes in the urinary metabolome at different time points | [ | |
| Spot urine samples of free-living population. | Predictive model of dietary walnut exposure | [ | |
| Urinary metabolome in free-living population. | Improved predictive model of dietary exposure to cocoa by combining different metabolites as biomarkers | [ | |
| Urinary metabolome in elderly men and women. | Greater hippurate after Med+CoQ and higher phenylacetylglycine levels after SFA diet in women | [ | |
| miRNA-410/rs13702 in the 3′untranslated region (3′UTR) of the lipoprotein lipase (LPL) gene. | Disruption of the recognition element seed site, gain-of-function, and lower TG. | [ | |
| miRNA-410/rs13702 C allele carriers. | Stroke incidence modulated by diet by decreasing TG and stroke risk after a high-unsaturated fat Mediterranean diet | [ | |
ADRB2: adrenoreceptor beta 2, surface; ARHGAP15: Rho GTPase activating protein 15; CLOCK: circadian locomotor output cycles kaput; CVD: cardiovascular disease; IFNγ: interferon gamma; IL7R: interleukin 7 receptor; LDL-C: low density lipoprotein cholesterol; MCP1: chemokine (C-C motif) ligand 2; MetS: Metabolic Syndrome; MLXIPL: Max-like protein X interacting protein-like; POLK: polymerase (DNA directed) kappa; PPARγ2: peroxisome proliferator-activated receptor gamma; TCF7L2: transcription factor 7-like 2; TG: triglycerides; TNFα: tumor necrosis factor α.